Take Action
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Backgrounder
Biosimilars Bulletin
Blog
Council Resource
Event
Handbook
Infographic
Issue Brief
Media
Member Spotlight
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Video
Whitepapers

In the News

New IQVIA Report: Biosimilars Driving Lower Prices and Greater Savings
January 31, 2023
Biosimilars Council Launches Educational Research for Leading Biosimilar Research
December 14, 2022
Raising Awareness for Biosimilars for Stakeholders Around the World
November 14, 2022
Biosimilar Medicines Generated $7 Billion in Savings in 2021
September 21, 2022
Senate passes inflation reduction act
AAM Statement on Senate Passage of Inflation Reduction Act
August 7, 2022
Inflation reduction act, biosimilars
Inflation Reduction Act Would Stifle Biosimilar Competition and Savings
August 3, 2022

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

Recent Tweets

Biosimilars CouncilFollow2,74610,013

Biosimilars Council advocates for policies that support patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/73dlNwCdqQ…

Biosimilars Council
BiosimsCouncil avatarBiosimilars Council@BiosimsCouncil·
3 Feb 1621598493478363137

Yesterday was National #RheumatoidArthritis Awareness Day! RA brings pain to more than 1.5 million Americans, but relief is on the horizon as #biosimilar versions of #Humira become available.

Check out our blog from last year: https://bit.ly/3JjHLmG

#autoimmune

Twitter feed video.
Image for the Tweet beginning: Yesterday was National #RheumatoidArthritis Awareness
Reply on Twitter 1621598493478363137Retweet on Twitter 1621598493478363137Like on Twitter 16215984934783631371Twitter 1621598493478363137
BiosimsCouncil avatarBiosimilars Council@BiosimsCouncil·
3 Feb 1621571337650163713

BOOK NOW! This year, #Access2023, the @AccessibleMeds annual meeting, will feature special guest @mcuban!

Immediately following Access!, IGBA will host its annual meeting in the SAME LOCATION!

Sign up today: https://access.accessiblemeds.org

Twitter feed video.
Image for the Tweet beginning: BOOK NOW! This year, #Access2023,
Reply on Twitter 1621571337650163713Retweet on Twitter 1621571337650163713Like on Twitter 1621571337650163713Twitter 1621571337650163713
BiosimsCouncil avatarBiosimilars Council@BiosimsCouncil·
1 Feb 1620826521999998976

Another clear example of how #PBM rebate schemes keep #drugprices high for patients: "When 5% off is a better deal than 55% off."

Read more in @statnews:
https://www.statnews.com/pharmalot/2023/01/31/amgen-humira-biosimilar-pbm-rebates-insurers/

#biosimilars #Humira #adalimumab

Twitter feed video.
Image for the Tweet beginning: Another clear example of how
Reply on Twitter 1620826521999998976Retweet on Twitter 1620826521999998976Like on Twitter 1620826521999998976Twitter 1620826521999998976
Load More...